AU2001290949A1 - Id-1 and id-2 genes and products as diagnostic and prognostic markers and therapeutic targets for treatment of breast cancer and other types of carcinoma - Google Patents
Id-1 and id-2 genes and products as diagnostic and prognostic markers and therapeutic targets for treatment of breast cancer and other types of carcinomaInfo
- Publication number
- AU2001290949A1 AU2001290949A1 AU2001290949A AU9094901A AU2001290949A1 AU 2001290949 A1 AU2001290949 A1 AU 2001290949A1 AU 2001290949 A AU2001290949 A AU 2001290949A AU 9094901 A AU9094901 A AU 9094901A AU 2001290949 A1 AU2001290949 A1 AU 2001290949A1
- Authority
- AU
- Australia
- Prior art keywords
- carcinoma
- genes
- diagnostic
- products
- types
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G01N33/5751—
-
- G01N33/57515—
-
- G01N33/57555—
-
- G01N33/57557—
-
- G01N33/5759—
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23255800P | 2000-09-14 | 2000-09-14 | |
| US23252900P | 2000-09-14 | 2000-09-14 | |
| US60/232,529 | 2000-09-14 | ||
| US60/232,558 | 2000-09-14 | ||
| PCT/US2001/028811 WO2002022858A1 (en) | 2000-09-14 | 2001-09-14 | Id-1 and id-2 genes and products as diagnostic and prognostic markers and therapeutic targets for treatment of breast cancer and other types of carcinoma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001290949A1 true AU2001290949A1 (en) | 2002-03-26 |
Family
ID=26926089
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001290949A Abandoned AU2001290949A1 (en) | 2000-09-14 | 2001-09-14 | Id-1 and id-2 genes and products as diagnostic and prognostic markers and therapeutic targets for treatment of breast cancer and other types of carcinoma |
Country Status (5)
| Country | Link |
|---|---|
| US (4) | US7429457B2 (en) |
| EP (1) | EP1326996A4 (en) |
| AU (1) | AU2001290949A1 (en) |
| CA (1) | CA2422320A1 (en) |
| WO (1) | WO2002022858A1 (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1326996A4 (en) * | 2000-09-14 | 2005-08-24 | Univ California | ID-1 AND ID-2 GENES AND PRODUCTS AS DIAGNOSTIC OR PROGNOSTIC MARKERS AND THERAPEUTIC TARGETS FOR THE TREATMENT OF BREAST CANCER AND OTHER TYPES OF CARCINOMA |
| WO2002044417A2 (en) * | 2000-11-28 | 2002-06-06 | Wyeth | Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| ES2343318T3 (en) * | 2002-11-26 | 2010-07-28 | University Of Massachusetts | ARNSIS ADMINISTRATION. |
| WO2006118564A2 (en) * | 2004-04-29 | 2006-11-09 | Washington State University Research Foundation | MODIFIED CELLS EXPRESSING A PROTEIN THAT MODULATES ACTIVITY OF bHLH PROTEINS, AND USES THEREOF |
| US9084771B2 (en) * | 2007-05-17 | 2015-07-21 | Sutter West Bay Hospitals | Methods and compositions for treating cancer |
| GB2475183B (en) * | 2008-06-04 | 2011-11-23 | Gw Pharma Ltd | Cannabinoids in combination with non-cannabinoid chemotherapeutic agent that are selective estrogen receptor modulators |
| GB2471987B (en) * | 2008-06-04 | 2012-02-22 | Gw Pharma Ltd | Anti-tumoural effects of cannabinoid combinations |
| AU2011207563B2 (en) * | 2010-01-19 | 2016-03-10 | Northwestern University | Synthetic nanostructures including nucleic acids and/or other entities |
| GB2478595B (en) | 2010-03-12 | 2018-04-04 | Gw Pharma Ltd | Phytocannabinoids in the treatment of glioma |
| GB2487712B (en) | 2011-01-04 | 2015-10-28 | Otsuka Pharma Co Ltd | Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy |
| GB2514054A (en) | 2011-09-29 | 2014-11-12 | Gw Pharma Ltd | A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD) |
| US9254272B2 (en) | 2011-11-30 | 2016-02-09 | Sutter West Bay Hospitals | Resorcinol derivatives |
| PT2790737T (en) * | 2011-12-12 | 2019-02-28 | Childrens Hospital Philadelphia | Large commercial scale lentiviral vector production system and vectors produced thereby |
| GB2516814B (en) | 2013-06-19 | 2016-08-31 | Otsuka Pharma Co Ltd | Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5650435A (en) * | 1991-04-01 | 1997-07-22 | Madara; James L. | Modulation of inflammation related to columnar epithelia |
| US6048850A (en) | 1992-09-22 | 2000-04-11 | Young; Donald A. | Method of inhibiting prostaglandin synthesis in a human host |
| US6506559B1 (en) * | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA |
| US6372433B1 (en) * | 2000-04-28 | 2002-04-16 | Isis Pharmaceuticals, Inc. | Antisense modulation of inhibitor of DNA binding-1 expression |
| EP1326996A4 (en) * | 2000-09-14 | 2005-08-24 | Univ California | ID-1 AND ID-2 GENES AND PRODUCTS AS DIAGNOSTIC OR PROGNOSTIC MARKERS AND THERAPEUTIC TARGETS FOR THE TREATMENT OF BREAST CANCER AND OTHER TYPES OF CARCINOMA |
| WO2002044417A2 (en) * | 2000-11-28 | 2002-06-06 | Wyeth | Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| US7267951B2 (en) * | 2002-06-05 | 2007-09-11 | Sloan-Kettering Institute For Cancer Research | Method for evaluating a tissue or biopsy sample to determine if the sample is early-stage melanoma |
-
2001
- 2001-09-14 EP EP01971012A patent/EP1326996A4/en not_active Withdrawn
- 2001-09-14 CA CA002422320A patent/CA2422320A1/en not_active Abandoned
- 2001-09-14 US US09/952,534 patent/US7429457B2/en not_active Expired - Lifetime
- 2001-09-14 WO PCT/US2001/028811 patent/WO2002022858A1/en not_active Ceased
- 2001-09-14 AU AU2001290949A patent/AU2001290949A1/en not_active Abandoned
-
2006
- 2006-03-27 US US11/390,682 patent/US8030012B2/en not_active Expired - Fee Related
-
2008
- 2008-12-02 US US12/326,832 patent/US8846629B2/en not_active Expired - Fee Related
-
2011
- 2011-10-03 US US13/252,148 patent/US8809291B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US8846629B2 (en) | 2014-09-30 |
| US20090180988A1 (en) | 2009-07-16 |
| US8809291B2 (en) | 2014-08-19 |
| EP1326996A1 (en) | 2003-07-16 |
| US7429457B2 (en) | 2008-09-30 |
| US20020137064A1 (en) | 2002-09-26 |
| US8030012B2 (en) | 2011-10-04 |
| CA2422320A1 (en) | 2002-03-21 |
| WO2002022858A1 (en) | 2002-03-21 |
| US20120021047A1 (en) | 2012-01-26 |
| EP1326996A4 (en) | 2005-08-24 |
| WO2002022858A9 (en) | 2004-04-22 |
| US20060234273A1 (en) | 2006-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001229340A1 (en) | Genes compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer | |
| AU1807401A (en) | Compositions and methods for therapy and diagnosis of breast cancer | |
| AU2001290949A1 (en) | Id-1 and id-2 genes and products as diagnostic and prognostic markers and therapeutic targets for treatment of breast cancer and other types of carcinoma | |
| AU2001241541A1 (en) | Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of human prostate cancer | |
| AU1656501A (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
| AU2002322280A1 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer | |
| AU7994200A (en) | Compositions and methods for therapy and diagnosis of prostate cancer | |
| AU2001249549A1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
| WO2004113571A3 (en) | Prostate specific genes and the use thereof as targets for prostate cancer therapy and diagnosis | |
| PL365244A1 (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
| AU6328196A (en) | Targets for breast cancer diagnosis and treatment | |
| AU3391200A (en) | Compositions and methods for breast cancer therapy and diagnosis | |
| AU2002251366A1 (en) | Proteins, genes and their use for diagnosis and treatment of breast cancer | |
| AU2001251613A1 (en) | Novel genes, compositions and methods for the identification, assessment, prevention, and therapy of human cancers | |
| AU2001268467A1 (en) | Identification of genes and compounds for treatment of cancer | |
| AU2001240909A1 (en) | Proteins, genes and their use for diagnosis and treatment of breast cancer | |
| AU6583700A (en) | Proteins, genes and their use for diagnosis and treatment of breast cancer | |
| IL142340A0 (en) | Methods for identification, diagnosis, and treatment of breast cancer | |
| AU2001243349A1 (en) | Methods for the diagnosis and treatment of breast cancer | |
| AU2596901A (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer | |
| AU2002313726A1 (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
| AU5638400A (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
| AU2003245927A1 (en) | Target genes for the diagnosis and treatment of cancer | |
| AU3177500A (en) | Proteins for diagnosis and treatment of breast cancer | |
| ZA200108256B (en) | Compositions and methods for the treatment and diagnosis of breast cancer. |